Micro-X Secures $2.3M from ARPA-H, Billion Prima, and DHS Milestones
Micro-X has successfully met key development milestones worth $2.3 million across contracts with ARPA-H, Billion Prima, and the US Department of Homeland Security, marking steady progress in its innovative medical and security imaging technologies.
- Achieved $1.4M milestone for Full Body CT scanner with ARPA-H
- Delivered $0.9M milestone for baggage scanning unit with Billion Prima
- Installed first self-screening checkpoint module at DHS test lab
- All projects progressing on time and within budget
- Preparing for human imaging trials and commercial launches
Micro-X Advances Key Development Contracts
Australian medical imaging innovator Micro-X Ltd (ASX – MX1) has announced the achievement of significant development milestones totaling AU$2.3 million across three major contracts. These milestones reflect steady progress in the company’s cutting-edge cold cathode x-ray technology, which promises to reshape both healthcare diagnostics and security screening.
Under its contract with the US Advanced Research Projects Agency for Health (ARPA-H), Micro-X reached Milestone 3 for its Full Body CT scanner project, earning AU$1.4 million. This milestone involved the submission and acceptance of a detailed technical dossier, marking a critical step toward prototype development. The lightweight scanner aims to deliver advanced imaging capabilities with enhanced portability, a potential game-changer for medical diagnostics.
Strategic Partnership with Billion Prima
Micro-X also achieved Milestone 2 under its strategic partnership with Malaysian firm Billion Prima Sdn Bhd, securing AU$0.9 million. This project focuses on developing a baggage and parcel scanning unit powered by Micro-X’s proprietary NEX technology. Billion Prima holds exclusive manufacturing and sales rights for the device in Southeast Asia for 20 years, positioning Micro-X to tap into a lucrative regional security market. The partnership is on track for a commercial launch by the end of 2025.
Progress with US Department of Homeland Security
Further progress was made on the US Department of Homeland Security (DHS) contract, with Micro-X delivering and installing the first self-screening checkpoint module at a DHS test laboratory. This milestone underscores the company’s growing footprint in security applications and its ability to meet stringent government requirements. To date, Micro-X has invoiced AU$5.6 million under this contract, with additional funding available through May 2026 and options for extension.
Looking Ahead
CEO Kingsley Hall highlighted the company’s focus on timely delivery and strong partnerships, noting ongoing preparations for human imaging trials of their Head CT device. With multiple projects advancing simultaneously and all tracking to plan, Micro-X is well positioned to capitalize on its innovative technology across health and security sectors.
Bottom Line?
Micro-X’s milestone achievements set the stage for upcoming trials and commercial rollouts that could redefine medical imaging and security screening.
Questions in the middle?
- When will Micro-X announce results from the upcoming human imaging trials?
- How might the DHS contract extension impact Micro-X’s revenue and growth trajectory?
- What are the commercial launch timelines and market expectations for the baggage scanning unit?
